Pemetrexed plus cetuximab in patients (pts) with recurrent non-small cell lung cancer (NSCLC): A phase I-IIa dose-ranging study from the Hoosier Oncology Group

Oncologist,2008, 引用: 48

Therapeutics and Clinical Risk Management,2008, 引用: 11

Pharmacogenomics and Personalized Medicine,2009, 引用: 0

Clinical Lung Cancer,2009, 引用: 22

Clinical Lung Cancer,2009, 引用: 4

European Journal of Cancer,2009, 引用: 99

Expert Review of Anticancer Therapy,2009, 引用: 7

OncoTargets and Therapy,2009, 引用: 1

Current Drug Targets,2010, 引用: 8

Oncologist,2009, 引用: 30